Drug DrugBank | All Description Patterns
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z other
No. | Drug (Description in trials) | DrugBank | KEGG DRUG * | KEGG GENES * [Number of genes] |
KEGG PATHWAY [Number of pathways] |
Disease ID * [Number of diseases] |
1 | Active bmn 111: daily subcutaneous injection of 15 ug/kg of bmn 111 | - | - | - | - | [1] 276 |
2 | Bmn 111 | - | - | - | - | [1] 276 |
3 | Modified recombinant human c-type natriuretic peptide | - | - | - | - | [1] 276 |
4 | Modified rhcnp | - | - | - | - | [1] 276 |
5 | Normal saline | - | - | - | - | [14] 6, 17, 22, 36, 46, 49, 60, 94, 96, 211, 226, 276, 296, 299 |
6 | Somatropin | Somatotropin | D02691 | [1] GHR | [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway | [15] 2, 3, 19, 46, 74, 75, 78, 96, 113, 193, 195, 265, 274, 276, 299 |
7 | Transcon cnp | - | - | - | - | [1] 276 |
8 | Vosoritide | Vosoritide | D11190 | - | - | [1] 276 |